Stockscreener 앱 받기
11.97
10.00%
-1.33
전일 마감가:
$13.30
열려 있는:
$13.3
하루 거래량:
975.12K
Relative Volume:
1.72
시가총액:
$740.05M
수익:
$1.12B
순이익/손실:
$55.30M
주가수익비율:
12.60
EPS:
0.95
순현금흐름:
$-30.30M
1주 성능:
-5.97%
1개월 성능:
-5.38%
6개월 성능:
-22.97%
1년 성능:
-15.47%
1일 변동 폭
$11.69
$13.38
1주일 범위
$11.69
$13.45
52주 변동 폭
$10.83
$21.48
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
EMBC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
11.97 | 740.05M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Embecta Corp. (NASDAQ:EMBC) Q2 2025 Earnings Call Transcript - Insider Monkey
Embecta Q2 2025 slides: Revenue decline offset by margin improvement and debt reduction - Investing.com
Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline By GuruFocus - Investing.com Canada
Embecta Corporation Reports Q2 2025 Financial Results - TipRanks
Embecta earnings beat by $0.17, revenue topped estimates - Investing.com Nigeria
Embecta Corp’s Earnings Call: Progress Amid Challenges - TipRanks
Embecta to undergo further restructuring, lowers guidance amid tariff impact - MassDevice
Embecta reports Q2 adjusted EPS 70c, consensus 59c - TipRanks
Embecta Q2 2025 Earnings Call Transcript - MarketBeat
Transcript : Embecta Corp., Q2 2025 Earnings Call, May 09, 2025 - marketscreener.com
Why Is Embecta Stock Falling On Friday? - Yahoo
EMBC Reports Q2 Revenue Slightly Below Expectations, Adjusts Gui - GuruFocus
Embecta Keeps Quarterly Dividend at $0.15 a Share; Payable June 13 to Holders of Record as of May 28 - marketscreener.com
Earnings call transcript: Embecta Q2 2025 beats EPS forecast, stock dips - Investing.com UK
embecta Announces Quarterly Cash Dividend - GlobeNewswire
Embecta Corp. (EMBC) Tops Q2 Earnings Estimates - Yahoo Finance
Embecta beats Q2 expectations, maintains full-year EPS outlook By Investing.com - Investing.com Nigeria
Embecta beats Q2 expectations, maintains full-year EPS outlook - Investing.com Australia
What Is Embecta Corp.'s (NASDAQ:EMBC) Share Price Doing? - simplywall.st
EMBC Reports Q2 Revenue Slightly Below Expectations, Adjusts Guidance | EMBC Stock News - GuruFocus
Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results - Stock Titan
Embecta Corp. Q2 Profit Decreases, But Beats Estimates - Nasdaq
Earnings Flash (EMBC) EMBECTA CORP. Posts Q2 Revenue $259M, vs. FactSet Est of $253.9M - marketscreener.com
Embecta Corp. Updates Earnings Guidance for the Fiscal Year 2025 - marketscreener.com
Is Now An Opportune Moment To Examine Embecta Corp. (NASDAQ:EMBC)? - Yahoo Finance
Embecta Announces Quarterly Cash Dividend - marketscreener.com
EMBECTA Earnings Preview: Recent $EMBC Insider Trading, Hedge Fund Activity, and More - Nasdaq
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference - The Globe and Mail
Embecta To Participate At The J.P. Morgan Global Leveraged Finance Conference - Barchart.com
Embecta Corp. to Host Analyst and Investor Day on May 22, 2025 in New York City - Nasdaq
Embecta to host Analyst and Investor Day on May 22, 2025 - Bluefield Daily Telegraph
Embecta Leaders to Reveal Long-term Growth Strategy and Financial Targets at Exclusive Investor Day - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
embecta to Report Fiscal Second Quarter 2025 Financial Results - The Manila Times
Embecta Corp. to Host Conference Call for Fiscal Q2 2025 Financial Results on May 9, 2025 - Nasdaq
Embecta Corp (EMBC) Stock Price Down 4.37% on Apr 14 - GuruFocus
Mizuho Initiates Coverage of Embecta (EMBC) with Neutral Recommendation - Nasdaq
Mizuho Initiates Embecta at Neutral With $15 Price Target - marketscreener.com
Mizuho sets Embecta stock with Neutral rating, $15 price target By Investing.com - Investing.com Canada
Mizuho sets Embecta stock with Neutral rating, $15 price target - Investing.com
Embecta Corporation: Hold Rating Amid Market Shifts and Strategic Uncertainties - TipRanks
(EMBC) Trading Advice - news.stocktradersdaily.com
Embecta shares study highlighting need for training, standardization in insulin delivery - Drug Delivery Business
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations - GlobeNewswire
Embecta Flat on Publication of Diabetes Education Piece - Baystreet.ca
Major Breakthrough: First Global Insulin Injection Guidelines in 10 Years Released by International Experts - Stock Titan
Embecta announces new publication in Mayo Clinic Proceedings on FITTER - TipRanks
Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%? - Yahoo Finance
embecta recognized as Healthcare Technology Company of the Year - The Healthcare Technology Report.
When the Price of (EMBC) Talks, People Listen - news.stocktradersdaily.com
Bank of New York Mellon Corp Purchases 4,769 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.40%
0.78%
자본화:
|
볼륨(24시간):